Clinical Trial Update: Application of 18F-CP6A PET Imaging in Synucleinopathies [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial is investigating the PET imaging tracer 18F-CP6A for synucleinopathies, with the study not yet recruiting. The sponsor is Union Hospital,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia with Lewy Bodies
• Multiple System Atrophy
• Parkinson Disease

Drugs mentioned

• 18F-CP6A

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Synucleinopathies | EARLY_Phase 1 | Status: NOT_YET_RECRUITING